FMI at Retinnovate 2025

Written By Peter Smyth

“Delighted to have the opportunity to represent the Future Medicines Institute at the excellent Retinnovate Conference.

Grateful to have the chance to present on regulatory pathways for retinal therapeutics in an engaging session with Tine Van Bergen from OcuRes Consult.

Thank you for the opportunity and look forward to seeing the progress of the wonderful innovators in attendance.“

-Dr. Stephen Liggett (FMI Director)

Peter Smyth
Previous

FMI visits the LYVA Labs Future Medicines Pre-Accelerator Introductory Day
Next

Medicines and Healthcare products Regulatory Agency (MHRA) visit to FMI